Morgan Stanley Upgrades Watson Pharmaceuticals to Overweight

Symbols: WPI
Share

Morgan Stanley has upgraded Watson Pharmaceuticals (NYSE: WPI) from Equal-weight to Overweight and has lowered the price target from $70 to $65.


 
 
< Previous
End-of-Day Market Summary for January 24, 2012
Next >
JP Morgan Upgrades Air Lease to Overweight
Share
Printer-friendly version
Send to friend
We're Loving

Benzinga's Premium Memberships

Benzinga's News Delivered Free

Brain Trust